D5B is a potent and selective PD-L1 inhibitor. D5B has been modified by DBCO. The EC50 of D5B degrading PD-L1 in 4T1 and B16-F10 tumor cells are 5.4 µM and 6.2 µM, respectively. D5B can block PD-L1/PD-1 interaction and has anti-tumor activity[1].
Molekulargewicht:
983.15
Formel:
C58H66N2O12
Target-Kategorie:
PD-1/PD-L1
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten